Posts With Tag Voting Rights

Explore AstraZeneca PLC's May 2025 Form 6-K report detailing 1.55B voting rights and regulatory compliance.

Explore AstraZeneca PLC's April 2025 financial report detailing voting rights, regulatory compliance, and company overview in the biopharmaceutical sector.

Ryanair Holdings PLC reveals Massachusetts Financial Services has crossed 5% voting rights threshold. Key investment insights & market implications highlighted.

Explore Ryanair Holdings PLC's February 2025 report detailing Baillie Gifford's voting rights acquisition, impacting investor insights. Key thresholds and voting rights revealed.

Explore AstraZeneca PLC's March 2025 Form 6-K detailing voting rights acquisition by The Capital Group, including percentage changes and compliance with regulatory standards.

Explore AstraZeneca PLC's latest 6-K filing revealing significant changes in voting rights by The Capital Group. Key insights on shareholder structure and ownership dynamics.

Ryanair Holdings PLC's Form 6-K reveals Capital Group's voting rights drop to 12.98%. Discover key insights on shareholder dynamics and investment strategies.

Vodafone Group Plc filed a Form 6-K/A on Jan 3, 2025, amending its issued share capital & total voting rights. Stay informed on key regulatory compliance and equity structure changes.

Explore Vodafone Group Plc's January 2025 Form 6-K detailing voting rights, share capital, and regulatory compliance. Essential for investors and stakeholders.

Explore Indivior PLC's January 2025 Form 6-K report detailing total voting rights, essential for shareholders. Signed by Kathryn Hudson, it's crucial for investor understanding.

Explore Nexxen International Ltd.'s January 2025 Form 6-K detailing Total Voting Rights, shareholder governance, and regulatory compliance.

Explore Ryanair's January 2025 report detailing 1,080,975,095 voting rights, share capital, and regulatory compliance. Essential for investors and analysts.